SVG Sprites

Press

Press Releases 03.18.2021

Xavier Becerra’s confirmation as HHS Secretary is crucial for lower Rx prices

Secretary Becerra has the skills and experience to help America tackle some of the most pressing issues before us: a raging pandemic, inaccessible healthcare, and sky-high prescription drug prices. We’re glad the Senate has finally approved him so he can get to work for the American people.  

Press Releases 03.18.2021

National Coalition of 60 Social, Racial and Economic Justice Organizations Urges Congressional Leaders to Lower Drug Prices in Next Package

In a new letter to Democratic leaders in Congress, Lower Drug Prices Now—a coalition of 60 social, racial, and economic justice organizations representing millions of Americans struggling with high prescription drug prices—urges House Speaker Nancy Pelosi and Senate Majority Leader Chuck Schumer to pass a strong H.R. 3, the Lower Drug Costs Now Act in order to make prescription drugs more affordable and hold the pharmaceutical industry accountable for price gouging and pandemic profiteering.   

Press Releases 03.16.2021

Anti-monopoly’s next target: Big Pharma

This announcement from the Federal Trade Commission is big news, and an important step toward advancing a healthcare system that guarantees every American can afford the medicines they need. 

Press Releases 03.10.2021

It’s time for Democrats to get serious about lowering drug prices.

The American Rescue Plan will expand access to Medicaid and make healthcare affordable for millions of people across the country, while simultaneously beginning to rein in Big Pharma’s price gouging. We will be watching to make sure that the Medicaid Rebate Cap provision will ultimately be implemented in 2024 rather than falling prey to Big Pharma lobbyists. Democrats have committed to put people before Big Pharma profits, and we’ll hold them to that.  

Press Releases 03.10.2021

Here’s what Biden should discuss when Big Pharma’s in the room

We all share President Biden’s goal to ensure that every person has access to a COVID vaccine, no matter where they live, what they look like, or how much money they have. To truly accomplish this, when the President meets with executives from Johnson & Johnson and Merck at the White House, he must discuss the industry’s active role in controlling access to the prescription drug through exclusive patents that guarantee the corporations big profits on all kinds of medicines–including ones funded by taxpayer dollars like COVID vaccines.    

Press Releases 03.04.2021

Senate’s delay of lifting Medicaid rebate cap would cost millions their healthcare

The Senate’s decision to delay the lifting of the Medicaid rebate cap shows just how much influence Big Pharma continues to have over lawmakers in Congress. Delaying the implementation of this provision until the next presidential election year almost guarantees that it won’t ever go into effect, denying health coverage to millions who need it most in order to keep boosting industry profits.

LDPN in the News 03.02.2021

Common Dreams: Experts Say J&J-Merck Deal—Though Welcome Step—Does Not Get to ‘Heart of the Matter’ on Vaccine Apartheid

In response to the Biden administration’s brokering of a deal wherein pharmaceutical giant Merck will utilize excess manufacturing capacity to produce the coronavirus vaccine of its longtime competitor, Johnson & Johnson, public health advocates said Tuesday that the partnership—though welcome—reveals how global vaccine supplies could be significantly increased if patent monopolies were dissolved and the technology controlled by Big Pharma shared worldwide. …

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles